STAT+: AbbVie wins FDA nod for Parkinson’s pill

Stat News • 9/28/2026

Summary

AbbVie has received FDA approval for its once-daily pill for Parkinson's disease. This approval is based on a late-stage study that demonstrated the drug's effectiveness in improving symptoms.

Share:XRedditLinkedIn

Advertisement

Lindy Score Breakdown (V4.2)

53d
Age
1
Sources
from cluster
1278
Hours Since Seen
Final Score0/100
CategoryAntiLindy
StatusArchived
Recency Multiplier0% (0.5^1278/48)
Hero EligibleNo
Score is 0 because recency decay (0.5^1278/48 = 0.000000) reduced it below 0.5

Score BreakdownRisk 50

Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 53 days - proven survivor

Stories gain Lindy status through source reputation, network consensus, and time survival.

Breaking Similar stories